Product image of Hemlibra 105mg/0.7ml (Emicizumab) 105mg/0.7ml Vials supplied by GNH India

Hemlibra 105mg/0.7ml

Active Ingredient:
Emicizumab
Form:
Vials
Brand:
Hemlibra 105mg/0.7ml
Origin:
Japan

Hemlibra 105mg/0.7ml (Emicizumab Vials) 105mg/0.7ml

Hemlibra 105mg/0.7ml (Emicizumab) is a subcutaneous injection for hemophilia A treatment. This vial formulation supports routine prophylaxis to reduce bleeding episodes. Store between 2-8°C and protect from light. Always follow healthcare provider guidance.

Strength

105mg/0.7ml

Pack Size

1s

Storage

2-8°

Manufacturer / TM Owner

Roche Pharma

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Emicizumab is used to prevent or reduce the frequency of bleeding episodes in adults and children with hemophilia A. It may be prescribed for those with or without factor VIII inhibitors. This medication helps manage bleeding risk in patients who need long-term prophylaxis. Consult your doctor to determine if Hemlibra is appropriate for your condition.

Side Effects

  • Hemlibra works by bridging activated factor IX and factor X to restore blood clotting function. Patients may notice fewer bleeding episodes over time with consistent use. Some individuals experience injection site reactions, such as redness or swelling. Regular monitoring helps track treatment progress and adjust care as needed.

Precautions & Warnings

  • Keep Hemlibra refrigerated between 2-8°C and avoid freezing. Protect the vial from light by storing it in its original packaging. Do not use if the solution is discolored or contains particles. Always check the expiration date before administration. Dispose of used needles and vials safely according to local guidelines.

Avoid Interactions

  • Hemlibra may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Avoid combining it with bypassing agents unless directed by a healthcare professional. Inform your doctor about all medications you are taking to prevent potential interactions. Alcohol and certain supplements may also influence treatment outcomes.

Frequently Asked Questions

Hemlibra is used to prevent or reduce bleeding episodes in people with hemophilia A, including those with factor VIII inhibitors.

Hemlibra is given as a subcutaneous injection, typically under the skin of the abdomen, thigh, or upper arm.

Common side effects include injection site reactions like redness or swelling, and mild headaches.

No, Hemlibra must be refrigerated between 2-8°C and protected from light.

Yes, Hemlibra is approved for use in both adults and children with hemophilia A.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Emicizumab

Hemlibra 30mg

Hemlibra 30mg

30mg/1ml Vials
Hemlibra-60mg IND

Hemlibra-60mg IND

60mg/0.4ml Vials
Hemlibra-30mg

Hemlibra-30mg

30mg/ml Vials
Hemlibra 30 mg

Hemlibra 30 mg

30 MG SOLUTION

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT